Tahsin Ozatli
- 4.4 Жақсы • 17 пікірлер
- 2015 жылдар тәжірибе
- Түркия, Істанбұл, Istinye University Liv Hospital Bahcesehir
- Oncologist
Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.
Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.
Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology
Education:
Professional Experience:
Clinical Trials, Courses, Certifications:
Clinical Trials:
Courses:
Certifications:
Memberships:
Education
Career
Education
Experience
Education
Ondokuz Mayıs University Faculty of Medicine (1991)
KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)
Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)
Specializations
Cancer Surgery
Pancreatic Surgery
Bile Duct Surgery
Bariatric Metabolic Surgery
Oncological Surgery
Breast Surgery
Gastric cancer
Colon cancer
Thyroid Cancer
Obesity Surgery
Diabetes Surgeries
Dr. Baha Zengel is a general surgeon with expertise in breast, gallbladder, thyroid diseases, and hernia repairs. He graduated from Ege University Faculty of Medicine in 1990. In 2004, he earned a doctorate in Basic Oncology from Dokuz Eylül University. He became an Associate Professor of General Surgery in 2014 through the Inter-University Board.
Dr. Zengel is skilled in advanced surgical procedures. His experience includes skin and breast-conserving mastectomy, oncoplastic breast surgery, laparoscopic cholecystectomy, sentinel lymph node biopsy, and ROLL/SNOLL techniques. He has held important positions at Izmir Bozyaka Training and Research Hospital, including Education Officer.
He is a member of several professional associations. He serves on the Board of Directors of the Aegean Region Surgery Association and is a founding board member of the Basic Oncology Association.
Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.
Education and Training:
Graduated in Medicine and Surgery from the University of Navarra (1985).
Completed residency in Oncology in 1987.
Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).
Professional Experience:
Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).
Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).
Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).
Head of the Oncology Department at Hospital General de Villalba (2014–2019).
Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.
Certifications and Training:
Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.
Research and Publications:
Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.
1998–2000 — Conducted research on the genesis of cancer at The Royal Marsden Hospital (England).
Authored numerous peer-reviewed articles in scientific journals. Selected topics include:
Oncotype Dx Recurrence Score in BRCA1/2 germline mutation carriers with hormone receptor-positive breast cancer.
TP53 missense mutation recurrence in cancer patients of Arab descent.
Adjuvant autologous vaccine for stage III microscopic melanoma: biomarker survival and enhanced response to CTLA-4 blockade.
Prognostic significance of (R)CA15-3 assay in primary breast cancer.
Diagnostic and prognostic value of comparative thymidine kinase 1 (TK1) activity assays in breast cancer patient serum.
Complete remission in a BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma treated with cisplatin.
Autologous vaccine-induced antitumor and self-reactive immune responses in melanoma: impact on patient survival and dependence on MHC class II expression.
Israeli Society of Clinical Oncology
Israel Medical Association
Cancer Genetics Research Foundation Award
Landau Prize
Judith Segal Memorial Award
Posts and Affiliations
Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany
Lead Breast Cancer Research Program, Kliniken Essen-Mitte
Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)
Additional Roles
ESMO Faculty – Breast Cancer
Member of AWO Gyn – Commission for plastic and reconstructive surgery
Speaker of the AGIMed – Commission for Integrative Medicine of the AGO
Member of the Organ Commission Mamma of the AGO
Scientific Director of the WSG study group
Global PI, Head of clinical investigations and trials 27
IDMC´s, Steering Boards national and international
Scientific committee of international and national symposia in breast cancer and surgical oncology
Organization Memberships
Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,
European Academy of Senology, German Cancer Society, German Society of Gynecology and
Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,
Publications
Peer reviewed Publications: 322
First/Senior Author: 38
h-Index/i10-Index 66/232
Congress Abstracts/Proceedings: 443
Books/Book Chapter: 59
Invited oral Presentations/Lectures: 1032
Dr. Leng Yin is an experienced oncologist, specializing in liver, gallbladder, stomach, pancreas, intestinal tracts and breast treatments. She has worked in Fuda Hospital, Bumrungrad International Hospital and Royal Siriraj Hospital and is a member of The Chinese Anti-Cancer Association.
Dr. Tamar Jablonski-Perec is an oncologist at Hadassah Medical Center in Jerusalem. She holds a Doctor of Medical Sciences from the Hebrew University and has experience from the renowned Sloan-Kettering Cancer Center in New York. She is the Head of Institute of Oncology, Head of Breast Cancer Treatment Center, and Professor of the Department of Oncology at the Hebrew University. She is a member of several international cancer communities and was awarded a scholarship from the Hadassah Medical School.
Radiotherapy specialist, Oncologist
Dr. Beatrice Uziely is an experienced cancer specialist, specializing in breast cancer, metastasis treatment, application of hormone and chemotherapy. She has been the Head of Oncology Department at Hadassah Medical Center since 2001. She holds a degree in biology and a degree in medicine from the Hebrew University of Jerusalem, as well as a specialty in oncology and radiation oncology. She is an author of 59 publications devoted to cancer research, has 11 grants, and is a member of multiple professional associations.
Professor Bella Kaufman is a leading specialist in the treatment of breast cancer, with a focus on clinical radiotherapy and ISCORT. She has published numerous articles in 25 medical journals worldwide and has been awarded by the American organization ASCO. She is a member of the Israel Society of Clinical Oncology and Radiotherapy ISCORT and Secretary of the Israeli organization of treatment of breast cancer. She is a graduate of Hebrew University of Jerusalem and conducted training at the affiliated Hadassah Hospital.
Radiotherapist
Chief Physician of the Oncology Center, Oncologist